Clinical Trials
3
Active:2
Completed:0
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Phase 3
Active, not recruiting
- Conditions
- Vitiligo
- Interventions
- Procedure: NB-UVB Light
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Clinuvel, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06109649
- Locations
- 🇬🇧
CLINUVEL site, Manchester, United Kingdom
🇺🇸CLINUVEL Site, Cedar Park, Texas, United States
A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Clinuvel, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05210582
- Locations
- 🇺🇸
CLINUVEL Investigational site, Detroit, Michigan, United States
News
No news found